Literature DB >> 33712029

Extending the phenotypic spectrum of PRPF8, PRPH2, RP1 and RPGR, and the genotypic spectrum of early-onset severe retinal dystrophy.

Michalis Georgiou1,2, Naser Ali2, Elizabeth Yang2, Parampal S Grewal2, Tryfon Rotsos3, Nikolas Pontikos1,2, Anthony G Robson1,2, Michel Michaelides4,5.   

Abstract

PURPOSE: To present the detailed retinal phenotype of patients with Leber Congenital Amaurosis/Early-Onset Severe Retinal Dystrophy (LCA/EOSRD) caused by sequence variants in four genes, either not (n = 1) or very rarely (n = 3) previously associated with the disease.
METHODS: Retrospective case series of LCA/EOSRD from four pedigrees. Chart review of clinical notes, multimodal retinal imaging, electrophysiology, and molecular genetic testing at a single tertiary referral center (Moorfields Eye Hospital, London, UK).
RESULTS: The mean age of presentation was 3 months of age, with disease onset in the first year of life in all cases. Molecular genetic testing revealed the following disease-causing variants: PRPF8 (heterozygous c.5804G > A), PRPH2 (homozygous c.620_627delinsTA, novel variant), RP1 (homozygous c.4147_4151delGGATT, novel variant) and RPGR (heterozygous c.1894_1897delGACA). PRPF8, PRPH2, and RP1 variants have very rarely been reported, either as unique cases or case reports, with limited clinical data presented. RPGR variants have not previously been associated with LCA/EOSRD. Clinical history and detailed retinal imaging are presented.
CONCLUSIONS: The reported cases extend the phenotypic spectrum of PRPF8-, PRPH2-, RP1-, and RPGR-associated disease, and the genotypic spectrum of LCA/EOSRD. The study highlights the importance of retinal and functional phenotyping, and the importance of specific genetic diagnosis to potential future therapy.

Entities:  

Keywords:  Childhood blindness; EOSRD; Early onset retinal dystrophy; Inherited retinal dystrophy; LCA; Leber congenital amaurosis; PRPF8; PRPH2; RP1; RPGR; SECORD; Severe early childhood onset retinal dystrophy

Mesh:

Substances:

Year:  2021        PMID: 33712029      PMCID: PMC7953775          DOI: 10.1186/s13023-021-01759-8

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  43 in total

1.  A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay.

Authors:  Nadia Amrani; Robin Ganesan; Stephanie Kervestin; David A Mangus; Shubhendu Ghosh; Allan Jacobson
Journal:  Nature       Date:  2004-11-04       Impact factor: 49.962

2.  Mutations in a gene encoding a new oxygen-regulated photoreceptor protein cause dominant retinitis pigmentosa.

Authors:  E A Pierce; T Quinn; T Meehan; T L McGee; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

Review 3.  The role of Rds in outer segment morphogenesis and human retinal disease.

Authors:  Rafal Farjo; Muna I Naash
Journal:  Ophthalmic Genet       Date:  2006-12       Impact factor: 1.803

4.  The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes.

Authors:  H R Luo; G A Moreau; N Levin; M J Moore
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

Review 5.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

6.  Retinal degeneration slow (rds) in mouse results from simple insertion of a t haplotype-specific element into protein-coding exon II.

Authors:  J Ma; J C Norton; A C Allen; J B Burns; K W Hasel; J L Burns; J G Sutcliffe; G H Travis
Journal:  Genomics       Date:  1995-07-20       Impact factor: 5.736

7.  Long-term effect of gene therapy on Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Manjit S Mehat; Venki Sundaram; Scott J Robbie; Susie E Barker; Caterina Ripamonti; Anastasios Georgiadis; Freya M Mowat; Stuart G Beattie; Peter J Gardner; Kecia L Feathers; Vy A Luong; Suzanne Yzer; Kamaljit Balaggan; Ananth Viswanathan; Thomy J L de Ravel; Ingele Casteels; Graham E Holder; Nick Tyler; Fred W Fitzke; Richard G Weleber; Marko Nardini; Anthony T Moore; Debra A Thompson; Simon M Petersen-Jones; Michel Michaelides; L Ingeborgh van den Born; Andrew Stockman; Alexander J Smith; Gary Rubin; Robin R Ali
Journal:  N Engl J Med       Date:  2015-05-04       Impact factor: 91.245

8.  Loss of function mutations in RP1 are responsible for retinitis pigmentosa in consanguineous familial cases.

Authors:  Firoz Kabir; Inayat Ullah; Shahbaz Ali; Alexander D H Gottsch; Muhammad Asif Naeem; Muhammad Zaman Assir; Shaheen N Khan; Javed Akram; Sheikh Riazuddin; Radha Ayyagari; J Fielding Hejtmancik; S Amer Riazuddin
Journal:  Mol Vis       Date:  2016-06-10       Impact factor: 2.367

Review 9.  Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy.

Authors:  Jasdeep S Gill; Michalis Georgiou; Angelos Kalitzeos; Anthony T Moore; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2019-01-24       Impact factor: 4.638

10.  Retinal Structure in RPE65-Associated Retinal Dystrophy.

Authors:  Neruban Kumaran; Michalis Georgiou; James W B Bainbridge; Mette Bertelsen; Michael Larsen; Fiona Blanco-Kelly; Carmen Ayuso; Hoai Viet Tran; Francis L Munier; Angelos Kalitzeos; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

View more
  2 in total

Review 1.  Genetic dissection of non-syndromic retinitis pigmentosa.

Authors:  Aarti Bhardwaj; Anshu Yadav; Manoj Yadav; Mukesh Tanwar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

2.  Characterization of Retinal Function Using Microperimetry-Derived Metrics in Both Adults and Children With RPGR-Associated Retinopathy.

Authors:  Evgenia Anikina; Michalis Georgiou; James Tee; Andrew R Webster; Richard G Weleber; Michel Michaelides
Journal:  Am J Ophthalmol       Date:  2021-07-22       Impact factor: 5.258

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.